Ascendis Pharma A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$1.48 | -$1.48 | -$1.48 |
| Q2 2024 | 6 | -$1.46 | -$1.46 | -$1.46 |
| Q3 2024 | 9 | -$2.17 | $0.68 | -$1.51 |
| Q4 2024 | 3 | -$1.43 | -$1.43 | -$1.43 |
| Q1 2025 | 5 | -$1.27 | -$1.27 | -$1.27 |
| Q2 2025 | 8 | -$1.07 | -$1.07 | -$1.07 |
| Q3 2025 | 4 | -$0.40 | -$0.40 | -$0.40 |
| Q4 2025 | 5 | -$0.03 | -$0.03 | -$0.03 |
Ascendis Pharma A/S Earnings Date And Information
Ascendis Pharma A/S last posted its earnings results on Tuesday, September 3rd, 2024. The company reported $-2.05 earnings per share for the quarter, missing analysts' consensus estimates of $-1.54 by $0.51. The company had revenue of 36.18 M for the quarter and had revenue of 266.72 M for the year. Ascendis Pharma A/S has generated $-9 earnings per share over the last year ($-8.55 diluted earnings per share) and currently has a price-to-earnings ratio of -15.69. Ascendis Pharma A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Ascendis Pharma A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/02/2024 | Q2 2024 | -$1.57 | -$1.92 | -0.35 | $82.80 M | $36.18 M |
| 02/07/2024 | Q1 2024 | -$2.15 | -$2.30 | -0.15 | $95.89 M | |
| 02/07/2024 | Q4 2023 | -$2.15 | -$1.53 | 0.62 | $137.70 M | |
| 09/29/2023 | Q3 2023 | -$2.88 | $49.05 M | $48.03 M | ||
| 04/27/2023 | Q2 2023 | -$2.84 | -$2.16 | 0.68 | $37.24 M | $47.39 M |
| 04/27/2023 | Q1 2023 | -$2.84 | -$1.98 | 0.86 | $33.59 M | |
| 02/16/2023 | Q4 2022 | -$2.50 | -$3.70 | -1.2 | $22.90 M | |
| 08/10/2022 | Q3 2022 | -$2.11 | -$3.03 | -0.92 | $8.81 M | $15.29 M |
| 05/11/2022 | Q2 2022 | -$2.25 | -$1.46 | 0.79 | $5.60 M | $6.16 M |
| 05/11/2022 | Q1 2022 | -$2.25 | -$2.21 | 0.04 | $5.03 M | $6.83 M |
| 03/02/2022 | Q4 2021 | -$2.57 | -$1.97 | 0.6 | $3.07 M | $4.90 M |
| 11/10/2021 | Q3 2021 | -$2.60 | -$1.47 | 1.13 | $1.32 M | $1.11 M |
| 08/26/2021 | Q2 2021 | -$2.50 | $885,676 | $1.02 M | ||
| 08/26/2021 | Q1 2021 | -$1.17 | $1.93 M | $746,000 | ||
| 11/12/2020 | Q4 2020 | -$2.60 | $2.07 M | $535,000 | ||
| 11/12/2020 | Q3 2020 | -$2.31 | $1.63 M | $2.76 M | ||
| 05/19/2020 | Q2 2020 | -$1.43 | -$1.97 | -0.54 | $2.45 M | $1.44 M |
| 05/19/2020 | Q1 2020 | -$1.43 | -$1.32 | 0.11 | $2.33 M | $2.23 M |
| 11/18/2019 | Q4 2019 | -$1.37 | -$1.68 | -0.31 | $2.12 M | $2.51 M |
| 08/28/2019 | Q3 2019 | -$1.32 | -$0.53 | 0.79 | $1.53 M | $2.24 M |
Ascendis Pharma A/S Earnings: Frequently Asked Questions
-
When is Ascendis Pharma A/S's earnings date?
Ascendis Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
How can I listen to Ascendis Pharma A/S's earnings conference call?
The conference call for Ascendis Pharma A/S's latest earnings report can be listened to online.
-
How can I read Ascendis Pharma A/S's conference call transcript?
The conference call transcript for Ascendis Pharma A/S's latest earnings report can be read online.
-
How much revenue does Ascendis Pharma A/S generate each year?
Ascendis Pharma A/S (:ASND) has a recorded annual revenue of $266.72 M.
-
How much profit does Ascendis Pharma A/S generate each year?
Ascendis Pharma A/S (:ASND) has a recorded net income of $266.72 M. Ascendis Pharma A/S has generated $-8.55 earnings per share over the last four quarters.
-
What is Ascendis Pharma A/S's price-to-earnings ratio?
Ascendis Pharma A/S (:ASND) has a price-to-earnings ratio of -15.69 and price/earnings-to-growth ratio is -0.88.
